search
Back to results

Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes

Primary Purpose

Gestational Diabetes

Status
Completed
Phase
Not Applicable
Locations
Slovenia
Study Type
Interventional
Intervention
Telemedicine care
Standard care
Sponsored by
University Medical Centre Ljubljana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gestational Diabetes focused on measuring telemedicine, glycemic control, perinatal outcomes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • less then 30 weeks of gestation at enrolement
  • GDM diagnosis
  • at least moderate Slovenian language skills
  • willingness to participate

Exclusion Criteria:

  • more than 30 weeks of pregnancy
  • overt diabetes or fasting glucose >6.9 mmol/l at diagnosis
  • multiple pregnancy
  • poor Slovene language skills
  • history or bariatric surgery or other surgeries that induce malabsorbtion
  • use of systemic steroids prior to enrolment
  • presence of concomitant disease that could affect glucose control or self-management (e.g. uncontrolled psychiatric disorder)

Sites / Locations

  • University Medical Centre Ljubljana

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Telemedicine group

Standard care group

Arm Description

Outcomes

Primary Outcome Measures

Average fasting glucose concentration
Average fasting based on participant's SMBG in the 3rd trimester
Percentage of glucose readings in the target range
average percentage for the 3rd trimester
Compliance with SMBG
is defined as defined as the number of actual glucose measurements performed divided by the number of recommended glucose measurements*100
The percentage of individuals needing insulin treatment
Average postprandial glucose concentration
Average postprandial glucose based on participant's SMBG in the 3rd trimester

Secondary Outcome Measures

gestational weight gain
from pre-conception until labour
Newborn birth weight
LGA incidence
Gestational age at birth
Preterm birth
Incidence of preeclampsia
Incidence of caesarean section

Full Information

First Posted
June 27, 2022
Last Updated
August 25, 2022
Sponsor
University Medical Centre Ljubljana
search

1. Study Identification

Unique Protocol Identification Number
NCT05521893
Brief Title
Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes
Official Title
Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
March 12, 2020 (Actual)
Primary Completion Date
December 20, 2020 (Actual)
Study Completion Date
October 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Medical Centre Ljubljana

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This is a a single-centre, parallel, randomized controlled trial in women with gestational diabetes mellitus (GDM). Women are randomized to routine monthly prenatal clinic care (standard care group) or a group sending daily glucose readings via an application installed on a smartphone and monthly individual videoconferences replacing in-person visits (telemedicine group). The overall aim is to compare the effectiveness of the combine synchronous and asynchronous telemedicine care with the standard care in women with GDM.
Detailed Description
In our single-centre, parallel, randomized controlled trial in women with gestational diabetes (GDM) the investigators aim to compare the effectiveness of combined synchonous and asynchronous telemedicine care with the standard care. In the telemedicine group appointments are performed online via monthly scheduled videoconferences. Women also receive a smartphone with the installed application that enable transfer of the measured capillary glucose concetration at the same time it is performed. The glucose data sent by women are reviewed once per week and after that healthcare professionals contact women if necessary. On the other hand, in the standard care group, visits are scheduled normally on a monthly basis at the diabetes clinic. Intention-to-treat analysis is going to be performed. The investigators aim to compare glycemic control, gestational weight gain and perinatal data between groups. Student's t-test or Mann-Whitney U test will be used for normally or non-normally distributed variables. Differences between groups in categorical data will be calcuated by Chi square.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes
Keywords
telemedicine, glycemic control, perinatal outcomes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
105 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Telemedicine group
Arm Type
Experimental
Arm Title
Standard care group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Telemedicine care
Intervention Description
In the telemedicine group, the appointments are performed online via scheduled videoconferences, on a monthly basis. All women in the telemedicine group receive a smartphone with the installed application that enable transfer of the measured capillary glucose concentration.
Intervention Type
Other
Intervention Name(s)
Standard care
Intervention Description
In the standard care group, visits are scheduled at the diabetes clinic on a monthly basis.
Primary Outcome Measure Information:
Title
Average fasting glucose concentration
Description
Average fasting based on participant's SMBG in the 3rd trimester
Time Frame
1 month
Title
Percentage of glucose readings in the target range
Description
average percentage for the 3rd trimester
Time Frame
1 month
Title
Compliance with SMBG
Description
is defined as defined as the number of actual glucose measurements performed divided by the number of recommended glucose measurements*100
Time Frame
1 month
Title
The percentage of individuals needing insulin treatment
Time Frame
once during pregnancy
Title
Average postprandial glucose concentration
Description
Average postprandial glucose based on participant's SMBG in the 3rd trimester
Time Frame
1 month
Secondary Outcome Measure Information:
Title
gestational weight gain
Description
from pre-conception until labour
Time Frame
once during pregnancy
Title
Newborn birth weight
Time Frame
delivery
Title
LGA incidence
Time Frame
delivery
Title
Gestational age at birth
Time Frame
delivery
Title
Preterm birth
Time Frame
delivery
Title
Incidence of preeclampsia
Time Frame
delivery
Title
Incidence of caesarean section
Time Frame
delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: less then 30 weeks of gestation at enrolement GDM diagnosis at least moderate Slovenian language skills willingness to participate Exclusion Criteria: more than 30 weeks of pregnancy overt diabetes or fasting glucose >6.9 mmol/l at diagnosis multiple pregnancy poor Slovene language skills history or bariatric surgery or other surgeries that induce malabsorbtion use of systemic steroids prior to enrolment presence of concomitant disease that could affect glucose control or self-management (e.g. uncontrolled psychiatric disorder)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Drazenka Pongrac Barlovic
Organizational Affiliation
University Medical Centre Ljubljana
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Centre Ljubljana
City
Ljubljana
ZIP/Postal Code
1000
Country
Slovenia

12. IPD Sharing Statement

Learn more about this trial

Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes

We'll reach out to this number within 24 hrs